chr19-7560765-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001166114.2(PNPLA6):c.3816+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000158 in 1,583,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001166114.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- ataxia-hypogonadism-choroidal dystrophy syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- PNPLA6-related spastic paraplegia with or without ataxiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 39Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- cerebellar ataxia-hypogonadism syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Laurence-Moon syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- trichomegaly-retina pigmentary degeneration-dwarfism syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PNPLA6 | NM_001166114.2 | c.3816+1G>A | splice_donor_variant, intron_variant | Intron 29 of 31 | ENST00000600737.6 | NP_001159586.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PNPLA6 | ENST00000600737.6 | c.3816+1G>A | splice_donor_variant, intron_variant | Intron 29 of 31 | 1 | NM_001166114.2 | ENSP00000473211.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000160 AC: 4AN: 250248 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000168 AC: 24AN: 1431840Hom.: 0 Cov.: 26 AF XY: 0.0000140 AC XY: 10AN XY: 714142 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74300 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Hereditary spastic paraplegia 39 Pathogenic:1
This sequence change affects a donor splice site in intron 32 of the PNPLA6 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (no rsID available, gnomAD 0.009%). Disruption of this splice site has been observed in individual(s) with Oliver-McFarlane syndrome (PMID: 33141049). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.3846+1G>A. ClinVar contains an entry for this variant (Variation ID: 445982). Studies have shown that disruption of this splice site results in skipping of exon 32, but is expected to preserve the integrity of the reading-frame (PMID: 33141049). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at